OmicsX is a global life sciences market intelligence and business development support firm specializing in drug discovery innovation.
We help pharma companies, CROs, and business leaders identify high-value early-stage biotechs, explore emerging therapeutic platforms, and stay ahead of innovation trends in oncology, neurology, and next-gen modalities like ADCs and TPDs.

With over 15 years of expertise, OmicsX delivers curated, decision-ready insights through:
✔️ Deep-dive Intelligence Reports (e.g., ADC 2025, TPD 2025)
✔️ Proprietary Database of 6,000+ Active Drug Developers & 2,500+ CROs
✔️ AI-powered Custom GPTs (ADCgenius, TPDgenius) for real-time answers
✔️ Interactive Excel Datasets & Power BI Dashboards
✔️ Personalized Slack-Based Support & BD Strategy Inputs

Our intelligence is trusted by business development, search & evaluation, and competitive intelligence teams who want to scout faster, validate better, and partner smarter.

Unlike generic market research firms, we focus exclusively on early-stage and emerging innovators often missed by standard databases—especially in the preclinical space.

We also support CRO/CDMO teams by identifying outsourcing-ready biotechs and acting as their virtual business development arm during major partnering events.

If your business depends on staying ahead in drug discovery—OmicsX brings the intelligence and tools to make it happen.

OmicsX

Org chart

Teams

Offices